News & Updates

Carvedilol + Ivabradine HCl 6.25 mg/5 mg, 12.5 mg/5 mg, 25 mg/5 mg FC tab

Insulin glargine + Lixisenatide 100 u/mL + 50 mcg/mL solution for injection (3 mL pre-filled pen); 100 u/mL + 33 mcg/mL solution for injection (3 mL pre-filled pen)

Cefuroxime axetil 250 mg/5 mL Powd for oral susp

NaCl 0.65%, xylitol 2.5% (isotonic, buffered soln) nasal drops

NaCl 0.65% nasal drops

Insulin Glargine 300 units/mL pre-filled pen

Zinc gluconate 70 mg chewable tab, 70 mg/5 mL syr

The use of defibrotide therapy in critically ill patients with SARS-CoV-2 acute respiratory distress syndrome (ARDS) is well tolerated and appears to induce promising response rate, as shown in the results of a small open-label trial.